Lacey and Larkin Weigh In On The Joe Arpaio Presidential Pardon Case

In October last year, the District Judge in Arizona passed a ruling allowing the presidential pardon that was being granted to Joe Arpaio to go through. Joe was about to face an extremely long sentence for the numerous heinous crimes that he committed during his tenure as the Sheriff of Maricopa County.

Calling himself ‘America’s Toughest Sheriff’, Joe was a white supremacist who saw everyone belonging to another race as inferior.

To this effect, he inflicted numerous injustices on people of minority groups. During his tenure, he was known for falsely arresting and imprisoning people particularly belonging to the Latin American Community living in the state of Arizona. Read more: Lacey and Larkin Frontera Fund and Phoenix New Times | Wikipedia

He was known for bribing jurors to get them to pass judgements on people belonging to these communities, and so that they would be inflicted with harsher sentences for even minor offences.

During his tenure, he was also known for the inhuman conditions that the people in the prisons that he ran were kept in. These people were often inflicted with force violence on the hands of the people who Joe Arpaio had employed. Anyone who said anything against Joe Arpaio was immediately punished for their actions, and no one knows this better than Michael Lacey and Jim Larkin.

The two newsmen of the Phoenix New Times decided to release an article on Arpaio and the injustices that he was resorting to. This caused quite a stir, which ultimately led them to being arrested by Joe Arpaio. They were also falsely detained under false pretenses, because of what they had written about Arpaio.

Lacey and Larkin then decided to sue Arpaio upon their release because of the false arrest and the mental harm he had inflicted on them as a result of this. The case lasted for quite a while before it was finally settled by Maricopa County.

Lacey and Larkin received a huge settlement, and then decided to use it to start up the Lacey and Larkin Frontera Fund. The case was also what brought the actions of Arpaio to the timelight, and started the long drawn out case that ultimately led to him being given a prison sentence.

However, all of this changes with the presidential pardon that is being granted to him.

It was clear that Arpaio did have racist notions and had the intention of profiling people of this race to fulfill his ideals. Many people have put in countless hours of effort to bring justice to the man that caused so much distress to their lives.

The reason President Donald Trump decided to grant Arpaio the pardon was because of the relationship that they share. Arpaio has always been a staunch supporter of the Republican Party and has donated countless times to Trump’s presidential campaign.

Granting this pardon to Arpaio will also deem all of the acts that he has committed as dismissed, almost as if he had never committed them at all.

It gives people who have these racist notions a feeling like they are justified since the President is on their side, which is not going to be good for the society in any way.

Learn more about Jim Larkin and Michael Lacey:

Scott Rocklage Brings His Science Background With Him To Help Early Stage Entrepreneurs To Build A Solid Life-Science Business

Scott Rocklage is a Managing Partner of the life-science based venture capital firm, 5AM Ventures, and he has been so since 2004. He brings with him years of experience in the healthcare management industry as well as a background in science. Early on in life, Rocklage studied at the University of California, Berkeley where he earned a Bachelor’s of Science Degree in Chemistry. He went on to pursue and complete his Ph.D. in Chemistry at the Massachusetts Institute of Technology. It was there that he performed research in the lab of the Nobel Prize winner, Richard R. Schrock. Over the years, he also invented or was the co-inventor of more than 30 United States patents.


Scott Rocklage was the CEO of EPIRUS Biopharmaceuticals, Inc. and was also its Acting CEO for a period of time. He also worked with Amersham Health as its CEO and President and was the Co-President of Ilypsa, Inc. Previously, Rocklage sat as the President of Cubist Pharmaceuticals Inc. for seven years and also was its Founding Chief Executive Officer for nine years. Before this, he was the CEO and President of Nycomed Salutar, Inc. and the CEO, Chairman, and President of Nycomed Interventional, Inc. Today he sits as a part of the Board of Directors of Nouscom AG and works with MDS Proteomics, Inc. as a Director.


Scott Rocklage was the man responsible for the FDA approval of Cubicin, Omniscan, and Teslascan, and he has also worked on many other possible drug candidates. He has found that it is his skills of organization, prioritizing, and time management that have helped him to become the success he is. He has also learned that a company does its best when it focuses, heavily, on the selection of its team. This is where he says many business leaders get jammed up, and this has caused him problems in the past. It was when he learned to stop staying stuck on a bad employee hire that he found that his businesses would run more smoothly. He has expressed that it doesn’t matter what you do to try to motivate or change an employee that is not the right fit for your company. If they have a set of underlying deficiencies that cause them to do poorly, it’s best to not waste a lot of time trying to make them change. Instead, it’s best to move forward and focus on the rest of your team and work to find a better fit for your company.


Visit to learn more.